Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations

Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations

Laia Sans-Atxer,1 Dominique Joly2 1Department of Nephrology, Hospital del Mar, Institut Mar for Medical Research, Barcelona, Spain; 2Faculty of Medicine, Université Paris-Descartes, Assistance Publique-Hôpitaux de Paris, Service de Néphrologie, Hôpital Necke...

Full description

Bibliographic Details
Main Authors: Sans-Atxer L, Joly D
Format: Article
Language:English
Published: Dove Medical Press 2018-01-01
Series:International Journal of Nephrology and Renovascular Disease
Subjects:
Autosomal dominant polycystic kidney disease ADPKD treatment Tolvaptan
Online Access:https://www.dovepress.com/tolvaptan--in-the-treatment-of-autosomal-dominant-polycystic-kidney-di-peer-reviewed-article-IJNRD

Internet

https://www.dovepress.com/tolvaptan--in-the-treatment-of-autosomal-dominant-polycystic-kidney-di-peer-reviewed-article-IJNRD

Similar Items